Trump administration reportedly shortlisting CDC nominees
Source: SeekingAlpha
2026-03-21 12:24:28 ET
More on Pfizer, Moderna, etc.
- Pfizer: I'm Still Expecting A Massive Rebound
- Expect Pfizer To Comeback: Take The Dividend While Waiting For Capital Appreciation
- Pfizer: Cheap For A Reason
- Pfizer tells shareholders to reject mini-tender offer
- Pfizer posts late-stage trial win for Talzenna plus Xtandi in new prostate cancer indication
Read the full article on Seeking Alpha
For further details see:
Trump administration reportedly shortlisting CDC nominees
GlaxoSmithKline PLC
NASDAQ: GSK
GSK Trading
-0.63% G/L:
$54.505 Last:
2,167,463 Volume:
$54.58 Open:
GSK Latest News
March 13, 2026 11:44:00 am
GSK's RSV Vaccine, AREXVY, Approved in US for Expanded Age Indication in Adults Aged 18-49 Years at Increased Risk
February 23, 2026 01:13:00 pm
Bora Pharmaceuticals and GSK Sign $250M Five Year Global Manufacturing Contract
GSK Stock Data
$120,291,791,432
2,019,018,428
0.4%
538
N/A
Pharmaceuticals
Healthcare
GB
London
